Grimes & Company, Inc. Vbi Vaccines Inc Transaction History

Grimes & Company, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	BUY	$0.29 - $0.64 $771 - $1,703	2,661 Added 0.92%	293,030 $87,000
Q4 2022 Jan 25, 2023	BUY	$0.38 - $22.5 $557 - $33,030	1,468 Added 0.51%	290,369 $0
Q3 2022 Oct 28, 2022	BUY	$0.73 - $23.4 $2,539 - $81,408	3,479 Added 1.22%	288,901 $204,000
Q2 2022 Jul 22, 2022	BUY	$0.66 - $1.81 $2,867 - $7,864	4,345 Added 1.55%	285,422 $231,000
Q1 2022 May 06, 2022	BUY	$1.27 - $2.47 $58,567 - $113,906	46,116 Added 19.63%	281,077 $467,000
Q4 2021 Feb 01, 2022	SELL	$2.21 - $3.22 $50,827 - $74,056	-22,999 Reduced 8.92%	234,961 $550,000
Q3 2021 Nov 08, 2021	BUY	$2.8 - $3.72 $45,600 - $60,583	16,286 Added 6.74%	257,960 $802,000
Q2 2021 Aug 04, 2021	BUY	$2.61 - $4.17 $43,848 - $70,056	16,800 Added 7.47%	241,674 $810,000
Q1 2021 May 12, 2021	BUY	$2.91 - $4.32 $244,309 - $362,685	83,955 Added 59.58%	224,874 $699,000
Q4 2020 Feb 02, 2021	BUY	$2.15 - $3.5 $7,798 - $12,694	3,627 Added 2.64%	140,919 $388,000
Q3 2020 Nov 12, 2020	BUY	$2.77 - $6.17 $1,864 - $4,152	673 Added 0.49%	137,292 $393,000
Q2 2020 Jul 31, 2020	BUY	$0.87 - $3.13 $30,879 - $111,096	35,494 Added 35.1%	136,619 $424,000
Q1 2020 May 05, 2020	BUY	$0.73 - $1.91 $15,640 - $40,921	21,425 Added 26.88%	101,125 $96,000
Q4 2019 Feb 05, 2020	BUY	$0.48 - $1.38 $38,256 - $109,985	79,700 New	79,700 $110,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Grimes & Company, Inc. with notifications on news.